Name: UMIN ID:
Unique ID issued by UMIN | UMIN000005556 |
---|---|
Receipt number | R000006584 |
Scientific Title | Phase I / II study for appropriate dose of Erlotinib in patients with lung adenocarcinoma having the sensitive mutation to epidermal growth factor receptor (EGFR) - tyrosine kinase inhibitor (TKI) |
Date of disclosure of the study information | 2011/05/10 |
Last modified on | 2020/11/28 15:37:58 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2011/05/05 15:30:23 | ||
2 | Update | 2011/05/23 12:28:37 | Email1 |
|
3 | Update | 2011/08/24 20:19:40 | Post marketing survey by drug manufacture etc., specified by Japanese law. |
|
4 | Update | 2011/08/24 20:21:37 | Recruitment status |
|
5 | Update | 2011/11/05 12:53:38 | Results |
|
6 | Update | 2012/05/05 10:49:24 | Results |
|
7 | Update | 2013/06/07 20:17:39 | Results |
|
8 | Update | 2013/08/25 10:57:27 | Email |
|
9 | Update | 2013/08/25 10:58:09 | Recruitment status |
|
10 | Update | 2013/11/23 13:27:02 | Recruitment status Results |
|
11 | Update | 2013/11/23 16:36:10 | Results |
|
12 | Update | 2013/12/28 14:58:29 | Results Results |
|
13 | Update | 2014/05/16 03:41:24 | ||
14 | Update | 2015/05/11 10:59:02 | Results Results |
|
15 | Update | 2015/11/12 20:00:58 | Last follow-up date Results Results |
|
16 | Update | 2016/05/05 10:49:17 | Name of primary person or sponsor Institute Department Organization |
|
17 | Update | 2016/05/05 10:53:38 | Results Results |
|
18 | Update | 2017/05/08 11:00:14 | Results Results |
|
19 | Update | 2018/05/09 16:37:44 | Recruitment status Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results URL related to results and publications |
|
20 | Update | 2019/03/30 15:27:11 | 1st name of lead principal investigator Last name of lead principal investigator 1st name of lead principal investigator Last name of lead principal investigator Zip code Last name of contact person Last name of contact person Zip code Organization Organization Address Address Tel |
|
21 | Update | 2019/03/30 15:31:07 | Recruitment status Date of IRB |
|
22 | Update | 2019/03/30 15:33:31 | Number of participants that the trial has enrolled Results date posted Results Delayed Results Delay Reason Results Delay Reason |
|
23 | Update | 2020/11/28 15:37:58 | URL releasing protocol Publication of results Results Delayed Results Delay Reason Results Delay Reason Date of the first journal publication of results Baseline Characteristics Baseline Characteristics Participant flow Participant flow Adverse events Adverse events Outcome measures Outcome measures Plan to share IPD Plan to share IPD IPD sharing Plan description IPD sharing Plan description |